BioStrand is advancing technology for analyzing genetic data, which will drive innovation in the fields of precision medicine.
BioStrand has raised €2.0M across 1 funding round from 1 investor, most recently a Seed round in Apr 2020. Based in Diepenbeek, Belgium; founded 2019; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-04-06 | Seed | €2.0M |
| K & E |
| View deal → |
